More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Roche v. Aetna, Inc.
Healthcare, Notable
Lowey Dannenberg is defending Aetna in a class action related to state anti-subrogation laws. Minerley v. Aetna Inc., et al., 13-cv-1337 (D.N.J.). Lowey Dannenberg has defended and won dismissal of […]
Federated Investment Management Company, et al., v. Republic of Argentina
Antitrust
Lowey obtained emergency injunctive relief on behalf of Federated Investors, one of the largest investment firms in the country with over $363 billion in assets under management, preventing the Government […]
Juniper Networks
Notable
Lowey Dannenberg served as lead counsel, representing the New York City Pension Funds and related class members, alleging that Juniper Networks, Inc. fraudulently concealed the backdating of millions of stock […]
News
Lowey Dannenberg Appointed Co-Lead Counsel in Nelnet Breach Litigation
On January 30, 2023, Judge Cheryl R. Zwart appointed Lowey Dannenberg, P.C. as one of two Co-Lead Interim Class Counsel representing a proposed class of consumer plaintiffs in In re: Data Security Cases Against Nelnet Servicing, LLC, No. 4:22-cv-3191 (D. Neb.). The…
Blog
Pharma Industry Takes Advantage of COVID Epidemic to Mislead Investors
Recently, several major players in the pharmaceutical industry have faced severe shareholder scrutiny for misleading the public regarding their roles in the production of COVID-19 vaccines. The company to most recently fall in the limelight is Emergent Biosolutions (“Emergent”). Emergent had...